Pernix Therapeutics, Inc. (PTX) to Present at the Canaccord Genuity 32nd Annual Global Growth Conference
8/9/2012 10:37:41 AM
THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that Cooper Collins, President and Chief Executive Officer, will present at the Canaccord Genuity 32nd Annual Global Growth Conference on Thursday, August 16, 2012 at 8:30 a.m. EDT. The conference will be held at the InterContinental Boston in Boston, MA.
comments powered by